X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1637) 1637
Newspaper Article (203) 203
Publication (114) 114
Book / eBook (29) 29
Book Chapter (27) 27
Magazine Article (20) 20
Book Review (17) 17
Newsletter (11) 11
Conference Proceeding (10) 10
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1174) 1174
index medicus (819) 819
dermatology (817) 817
autoimmune diseases (747) 747
female (474) 474
male (433) 433
autoantibodies (406) 406
immunology (360) 360
pemphigus (351) 351
autoimmunity (344) 344
autoimmune diseases - immunology (326) 326
skin (324) 324
animals (316) 316
middle aged (305) 305
skin diseases (294) 294
disease (281) 281
adult (270) 270
aged (266) 266
bullous pemphigoid (228) 228
diagnosis (187) 187
antibodies (186) 186
autoantibodies - immunology (178) 178
autoimmune (169) 169
autoimmune diseases - drug therapy (169) 169
immunoglobulins (169) 169
pemphigus - immunology (166) 166
pemphigoid, bullous - immunology (162) 162
mice (158) 158
skin diseases, vesiculobullous - immunology (158) 158
research (156) 156
autoantigens - immunology (152) 152
autoimmune diseases - pathology (148) 148
autoimmune diseases - diagnosis (144) 144
analysis (141) 141
pemphigus vulgaris (141) 141
integumentary system (140) 140
care and treatment (135) 135
antigens (132) 132
autoantibodies - blood (130) 130
therapy (128) 128
aged, 80 and over (124) 124
rituximab (124) 124
pemphigoid (122) 122
patients (119) 119
pemphigus-vulgaris (117) 117
immunosuppressive agents - therapeutic use (116) 116
medicine & public health (115) 115
pathogenesis (114) 114
skin - pathology (111) 111
collagen (108) 108
medical research (108) 108
proteins (108) 108
inflammation (106) 106
antigen (103) 103
immunoglobulin g (103) 103
pemphigus - pathology (103) 103
systemic-lupus-erythematosus (101) 101
treatment outcome (101) 101
immunofluorescence (96) 96
diseases (94) 94
medicine (94) 94
paraneoplastic pemphigus (94) 94
pemphigus - drug therapy (94) 94
skin - immunology (94) 94
skin diseases, vesiculobullous - diagnosis (94) 94
immunoglobulins, intravenous - therapeutic use (91) 91
skin diseases, vesiculobullous - drug therapy (90) 90
pemphigoid, bullous - pathology (89) 89
autoimmune diseases - therapy (87) 87
child (87) 87
disease models, animal (87) 87
autoimmune disease (86) 86
vulgaris (85) 85
health aspects (82) 82
adolescent (81) 81
internal medicine (81) 81
immunoglobulin g - immunology (79) 79
skin and connective tissue diseases (79) 79
cell biology (78) 78
biopsy (76) 76
epidermolysis bullosa acquisita (74) 74
rheumatoid-arthritis (74) 74
allergy (73) 73
diagnosis, differential (73) 73
lupus (73) 73
skin diseases, vesiculobullous - pathology (73) 73
autoimmune-disease (72) 72
risk factors (72) 72
immune system (69) 69
medicine, experimental (69) 69
pemphigoid, bullous - drug therapy (69) 69
desmoglein 3 (67) 67
intravenous immunoglobulin (67) 67
retrospective studies (67) 67
corticosteroids (66) 66
immunoblotting (66) 66
immunotherapy (65) 65
dermatitis-herpetiformis (64) 64
fluorescent antibody technique (63) 63
vii collagen (63) 63
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1867) 1867
German (37) 37
French (9) 9
Spanish (5) 5
Japanese (4) 4
Korean (3) 3
Polish (3) 3
Turkish (3) 3
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Biological Therapy, ISSN 1471-2598, 02/2019, Volume 19, Issue 2, pp. 149 - 156
Introduction: Autoimmune blistering skin diseases are a group of disorders subdivided according to the location of blister formation: intraepidermal blistering... 
autoimmunity | pemphigus vulgaris | Autoimmune blistering diseases | pemphigoid | biological agents | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | COMPLEMENT ACTIVATION | ALPHA | CLINICAL-FEATURES | TARGETING B-CELLS | IGE AUTOANTIBODIES | PEMPHIGUS-VULGARIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | RITUXIMAB | SKIN
Journal Article
Journal Article
Journal Article
Journal Article
Clinical Reviews in Allergy & Immunology, ISSN 1080-0549, 2/2008, Volume 34, Issue 1, pp. 56 - 64
Autoimmune blistering diseases are associated with autoantibodies to desmosomal (pemphigus group) or hemidesmosomal proteins (autoimmune subepidermal... 
Allergology | MabThera | Therapy | Immunology | Medicine & Public Health | Bullous pemphigoid | Pemphigus | Autoantibody | B lymphocyte | Rituxan | Internal Medicine | Epidermolysis bullosa acquisita | RHEUMATOID-ARTHRITIS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | pemphigoid epidermolysis bullosa acquisita | B-CELL DEPLETION | FOLLICULAR LYMPHOMA | IMMUNOLOGY | Rituxan (TM) therapy | HEMOLYTIC-ANEMIA | PEMPHIGUS-VULGARIS | MabThera (TM) | ANTI-CD20 MONOCLONAL-ANTIBODY | EPIDERMOLYSIS-BULLOSA ACQUISITA | pemphigus | ALLERGY | PARANEOPLASTIC PEMPHIGUS | THROMBOCYTOPENIC PURPURA | autoantibody B lymphocyte bullous | Glucocorticoids - therapeutic use | Autoantibodies - blood | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Male | Female | Skin Diseases, Vesiculobullous - drug therapy | Child | Antibodies, Monoclonal - immunology | Autoimmune Diseases - drug therapy | Drug Resistance | Skin Diseases, Vesiculobullous - immunology | Autoimmune Diseases - classification | Antibodies, Monoclonal, Murine-Derived | Skin Diseases, Vesiculobullous - classification | Autoimmune Diseases - immunology | Immunologic Factors - immunology | Rituximab | Treatment Outcome | Aged | Immunologic Factors - adverse effects | Immunologic Factors - therapeutic use | Autoimmune diseases | Lymphomas
Journal Article
Drugs & Aging, ISSN 1170-229X, 10/2016, Volume 33, Issue 10, pp. 711 - 723
Elderly patients are more susceptible to the development of autoimmune blistering disorders such as bullous pemphigoid, mucous membrane pemphigoid,... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | DIFFERENTIAL-DIAGNOSIS | TOPICAL CORTICOSTEROIDS | THERAPY | INTRAVENOUS IMMUNOGLOBULIN | RITUXIMAB | EPIDERMOLYSIS-BULLOSA-ACQUISITA | DISORDERS | RISK | PHARMACOLOGY & PHARMACY | SKIN | PEMPHIGUS | GERIATRICS & GERONTOLOGY | Pemphigus - diagnosis | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Paraneoplastic Syndromes - epidemiology | Aging - drug effects | Antibodies, Monoclonal - adverse effects | Pemphigoid, Benign Mucous Membrane - drug therapy | Pemphigoid, Bullous - drug therapy | Antibodies, Monoclonal - therapeutic use | Paraneoplastic Syndromes - diagnosis | Skin Diseases, Vesiculobullous - epidemiology | Pemphigus - drug therapy | Epidermolysis Bullosa Acquisita - diagnosis | Aging - immunology | Paraneoplastic Syndromes - surgery | Pemphigoid, Benign Mucous Membrane - diagnosis | Pemphigus - epidemiology | Pemphigoid, Bullous - epidemiology | Skin Diseases, Vesiculobullous - drug therapy | Pemphigoid, Bullous - diagnosis | Autoimmune Diseases - drug therapy | Glucocorticoids - adverse effects | Immunosuppressive Agents - administration & dosage | Autoimmune Diseases - epidemiology | Skin Diseases, Vesiculobullous - diagnosis | Comorbidity | Autoimmune Diseases - diagnosis | Epidermolysis Bullosa Acquisita - drug therapy | Antibodies, Monoclonal - administration & dosage | Paraneoplastic Syndromes - drug therapy | Immunosuppressive Agents - adverse effects | Aged | Epidermolysis Bullosa Acquisita - epidemiology | Pemphigoid, Benign Mucous Membrane - epidemiology | Care and treatment | Research | Autoimmune diseases | Health aspects
Journal Article
Journal Article
Journal Article